These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20696662)

  • 1. Polymorphisms at the Microseminoprotein-beta locus associated with physiologic variation in beta-microseminoprotein and prostate-specific antigen levels.
    Xu X; Valtonen-André C; Sävblom C; Halldén C; Lilja H; Klein RJ
    Cancer Epidemiol Biomarkers Prev; 2010 Aug; 19(8):2035-42. PubMed ID: 20696662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A common prostate cancer risk variant 5' of microseminoprotein-beta (MSMB) is a strong predictor of circulating beta-microseminoprotein (MSP) levels in multiple populations.
    Waters KM; Stram DO; Le Marchand L; Klein RJ; Valtonen-André C; Peltola MT; Kolonel LN; Henderson BE; Lilja H; Haiman CA
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2639-46. PubMed ID: 20736317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine.
    Whitaker HC; Kote-Jarai Z; Ross-Adams H; Warren AY; Burge J; George A; Bancroft E; Jhavar S; Leongamornlert D; Tymrakiewicz M; Saunders E; Page E; Mitra A; Mitchell G; Lindeman GJ; Evans DG; Blanco I; Mercer C; Rubinstein WS; Clowes V; Douglas F; Hodgson S; Walker L; Donaldson A; Izatt L; Dorkins H; Male A; Tucker K; Stapleton A; Lam J; Kirk J; Lilja H; Easton D; ; ; ; Cooper C; Eeles R; Neal DE
    PLoS One; 2010 Oct; 5(10):e13363. PubMed ID: 20967219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer.
    Klein RJ; Halldén C; Cronin AM; Ploner A; Wiklund F; Bjartell AS; Stattin P; Xu J; Scardino PT; Offit K; Vickers AJ; Grönberg H; Lilja H
    Cancer Prev Res (Phila); 2010 May; 3(5):611-9. PubMed ID: 20424135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of beta-microseminoprotein in blood and risk of prostate cancer in multiple populations.
    Haiman CA; Stram DO; Vickers AJ; Wilkens LR; Braun K; Valtonen-André C; Peltola M; Pettersson K; Waters KM; Marchand LL; Kolonel LN; Henderson BE; Lilja H
    J Natl Cancer Inst; 2013 Feb; 105(3):237-43. PubMed ID: 23213189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of prostate cancer risk variants rs10993994 and rs7098889 by CRISPR/Cas9 mediated genome editing.
    Wang X; Hayes JE; Xu X; Gao X; Mehta D; Lilja HG; Klein RJ
    Gene; 2021 Feb; 768():145265. PubMed ID: 33122083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study.
    Grönberg H; Adolfsson J; Aly M; Nordström T; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Clements M; Egevad L; Eklund M
    Lancet Oncol; 2015 Dec; 16(16):1667-76. PubMed ID: 26563502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility.
    Lou H; Yeager M; Li H; Bosquet JG; Hayes RB; Orr N; Yu K; Hutchinson A; Jacobs KB; Kraft P; Wacholder S; Chatterjee N; Feigelson HS; Thun MJ; Diver WR; Albanes D; Virtamo J; Weinstein S; Ma J; Gaziano JM; Stampfer M; Schumacher FR; Giovannucci E; Cancel-Tassin G; Cussenot O; Valeri A; Andriole GL; Crawford ED; Anderson SK; Tucker M; Hoover RN; Fraumeni JF; Thomas G; Hunter DJ; Dean M; Chanock SJ
    Proc Natl Acad Sci U S A; 2009 May; 106(19):7933-8. PubMed ID: 19383797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MSMB gene rs10993994 polymorphism increases the risk of prostate cancer.
    Peng T; Zhang L; Zhu L; Mi YY
    Oncotarget; 2017 Apr; 8(17):28494-28501. PubMed ID: 28212531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Four-kallikrein Panel and β-Microseminoprotein in Predicting High-grade Prostate Cancer on Biopsy: An Independent Replication from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer.
    Assel M; Sjöblom L; Murtola TJ; Talala K; Kujala P; Stenman UH; Taari K; Auvinen A; Vickers A; Visakorpi T; Tammela TL; Lilja H
    Eur Urol Focus; 2019 Jul; 5(4):561-567. PubMed ID: 29137895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk.
    Chang BL; Cramer SD; Wiklund F; Isaacs SD; Stevens VL; Sun J; Smith S; Pruett K; Romero LM; Wiley KE; Kim ST; Zhu Y; Zhang Z; Hsu FC; Turner AR; Adolfsson J; Liu W; Kim JW; Duggan D; Carpten J; Zheng SL; Rodriguez C; Isaacs WB; Grönberg H; Xu J
    Hum Mol Genet; 2009 Apr; 18(7):1368-75. PubMed ID: 19153072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation in KLK2 and KLK3 is associated with concentrations of hK2 and PSA in serum and seminal plasma in young men.
    Sävblom C; Halldén C; Cronin AM; Säll T; Savage C; Vertosick EA; Klein RJ; Giwercman A; Lilja H
    Clin Chem; 2014 Mar; 60(3):490-9. PubMed ID: 24270797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic correction of PSA values using sequence variants associated with PSA levels.
    Gudmundsson J; Besenbacher S; Sulem P; Gudbjartsson DF; Olafsson I; Arinbjarnarson S; Agnarsson BA; Benediktsdottir KR; Isaksson HJ; Kostic JP; Gudjonsson SA; Stacey SN; Gylfason A; Sigurdsson A; Holm H; Bjornsdottir US; Eyjolfsson GI; Navarrete S; Fuertes F; Garcia-Prats MD; Polo E; Checherita IA; Jinga M; Badea P; Aben KK; Schalken JA; van Oort IM; Sweep FC; Helfand BT; Davis M; Donovan JL; Hamdy FC; Kristjansson K; Gulcher JR; Masson G; Kong A; Catalona WJ; Mayordomo JI; Geirsson G; Einarsson GV; Barkardottir RB; Jonsson E; Jinga V; Mates D; Kiemeney LA; Neal DE; Thorsteinsdottir U; Rafnar T; Stefansson K
    Sci Transl Med; 2010 Dec; 2(62):62ra92. PubMed ID: 21160077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients.
    Kader AK; Sun J; Isaacs SD; Wiley KE; Yan G; Kim ST; Fedor H; DeMarzo AM; Epstein JI; Walsh PC; Partin AW; Trock B; Zheng SL; Xu J; Isaacs W
    Prostate; 2009 Aug; 69(11):1195-205. PubMed ID: 19434657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer.
    Sjöblom L; Saramäki O; Annala M; Leinonen K; Nättinen J; Tolonen T; Wahlfors T; Nykter M; Bova GS; Schleutker J; Tammela TL; Lilja H; Visakorpi T
    PLoS One; 2016; 11(3):e0150241. PubMed ID: 26939004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of plasma microseminoprotein-beta in prostate cancer: an observational nested case-control and Mendelian randomization study in the European prospective investigation into cancer and nutrition.
    Smith Byrne K; Appleby PN; Key TJ; Holmes MV; Fensom GK; Agudo A; Ardanaz E; Boeing H; Bueno-de-Mesquita HB; Chirlaque MD; Kaaks R; Larrañaga N; Palli D; Perez-Cornago A; Quirós JR; Ricceri F; Sánchez MJ; Tagliabue G; Tsilidis KK; Tumino R; Fortner RT; Ferrari P; ; Riboli E; Lilja H; Travis RC
    Ann Oncol; 2019 Jun; 30(6):983-989. PubMed ID: 31089709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of prostate cancer susceptibility variant (MSMB) rs10993994 with risk of spermatogenic failure.
    Wu W; Lu J; Yuan B; Qin Y; Chen M; Niu X; Xu B; Lu C; Xia Y; Chen D; Sha J; Wang X
    Gene; 2013 Jul; 524(2):197-202. PubMed ID: 23608167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective validation of microseminoprotein-β added to the 4Kscore in predicting high-grade prostate cancer in an international multicentre cohort.
    Lonergan PE; Vertosick EA; Assel M; Sjoberg DD; Haese A; Graefen M; Boorjian SA; Klee GG; Cooperberg MR; Pettersson K; Routila E; Vickers AJ; Lilja H
    BJU Int; 2021 Aug; 128(2):218-224. PubMed ID: 33306251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-microseminoprotein in serum correlates with the levels in seminal plasma of young, healthy males.
    Valtonen-André C; Sävblom C; Fernlund P; Lilja H; Giwercman A; Lundwall A
    J Androl; 2008; 29(3):330-7. PubMed ID: 18222915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive resequence analysis of a 97 kb region of chromosome 10q11.2 containing the MSMB gene associated with prostate cancer.
    Yeager M; Deng Z; Boland J; Matthews C; Bacior J; Lonsberry V; Hutchinson A; Burdett LA; Qi L; Jacobs KB; Gonzalez-Bosquet J; Berndt SI; Hayes RB; Hoover RN; Thomas G; Hunter DJ; Dean M; Chanock SJ
    Hum Genet; 2009 Dec; 126(6):743-50. PubMed ID: 19644707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.